AUROBINDO PHARMA
|
AUROBINDO PHARMA Last 5 Year Cashflow Statement History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Profit Before Tax | ₹4,380 Cr | ₹2,613 Cr | ₹3,373 Cr | ₹7,344 Cr | ₹3,743 Cr |
Adjustment | ₹1,496 Cr | ₹1,586 Cr | ₹1,344 Cr | ₹-1,663 Cr | ₹1,091 Cr |
Changes In working Capital | ₹-1,675 Cr | ₹-1,095 Cr | ₹1,558 Cr | ₹-1,067 Cr | ₹308 Cr |
Cash Flow after changes in Working Capital | ₹4,201 Cr | ₹3,104 Cr | ₹6,275 Cr | ₹4,614 Cr | ₹5,142 Cr |
Cash Flow from Operating Activities | ₹2,435 Cr | ₹2,387 Cr | ₹5,016 Cr | ₹3,329 Cr | ₹4,381 Cr |
Cash Flow from Investing Activities | ₹-4,256 Cr | ₹-3,978 Cr | ₹-3,212 Cr | ₹599 Cr | ₹-1,568 Cr |
Cash Flow from Financing Activities | ₹800 Cr | ₹1,814 Cr | ₹-2,969 Cr | ₹-1,365 Cr | ₹-1,947 Cr |
Net Cash Inflow / Outflow | ₹-1,021 Cr | ₹223 Cr | ₹-1,164 Cr | ₹2,563 Cr | ₹866 Cr |
Opening Cash & Cash Equivalents | ₹4,392 Cr | ₹4,163 Cr | ₹5,330 Cr | ₹2,747 Cr | ₹1,876 Cr |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | - | ₹6.41 Cr | ₹-3.25 Cr | ₹22 Cr | - |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
Effect of Foreign Exchange Fluctuations | ₹14 Cr | ₹-0.06 Cr | ₹0.20 Cr | ₹-2.12 Cr | ₹4.78 Cr |
Closing Cash & Cash Equivalent | ₹3,385 Cr | ₹4,392 Cr | ₹4,163 Cr | ₹5,330 Cr | ₹2,747 Cr |
Compare Cashflow Statement of peers of AUROBINDO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AUROBINDO PHARMA | ₹72,059.9 Cr | -0.4% | 1.7% | 22.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹433,920.0 Cr | -0.1% | 1.7% | 45.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹155,160.0 Cr | -0.1% | -2.2% | 56.9% | Stock Analytics | |
CIPLA | ₹118,917.0 Cr | 1.7% | 0.5% | 23.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,017.0 Cr | 5.7% | 12.4% | 18.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,997.1 Cr | -1.4% | 3.1% | 44.8% | Stock Analytics |
AUROBINDO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AUROBINDO PHARMA | -0.4% |
1.7% |
22.9% |
SENSEX | -5% |
0.6% |
9.2% |
You may also like the below Video Courses